Christopher Kennedy

About

Christopher W. Kennedy is an award-winning healthcare leader. He has spent the last two decades in executive leadership roles within the Healthcare Provider, Biotechnology, and Medical Device sectors. His efforts in making Patient Experience a measurable outcome have been featured by The Beryl Institute, The Wharton School, a PBS TV Special, and a 2019 Ted Talk presentation. He actively serves on multiple industry advisory boards including MOBIO, URAC, NASP, and The Kauffman Foundation's Skilled KC initiative.

Christopher is recognized for pioneering innovative healthcare solutions. Currently, his focus is in the new drug development space specific to hematopoietic (HSC) and mesenchymal (MSC) stem cell research. He is leading a world-renowned scientific team in launching the first out-licensed technology from the Stowers Institute for Medical Research. Previously, Christopher was presented with the 2018 American Telemedicine Association (ATA) President's Award for Innovation for developing a virtual solution for rare disease care management. The Massachusetts Institute of Technology (MIT) “Hacking Medicine” program also highlighted Christopher’s work as a top-ranked breakthrough.

Christopher credits his time at The Wharton School for learning the fundamentals of "Innovation Tournaments" to more rapidly deliver critical healthcare solutions. He also studied under Michael Porter and Robert Kaplan at Harvard Business School’s Value-Based Care program to adopt the fundamentals of Time-Driven Activity-Based Costing (TDABC) for the launch of forward-looking healthcare models.